eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

3/2024
vol. 16
 
Share:
Share:
Original paper

MRI-guided brachytherapy for cervical cancer treatment: The significance of bladder morphology in dose distribution planning

Euncheol Choi
1, 2
,
Byungyong Kim
1
,
Sang Jun Byun
1, 2
,
Jin Hee Kim
1, 2
,
Seung Gyu Park
1, 2
,
Myeongsoo Kim
1

  1. Department of Radiation Oncology, Keimyung University, Dongsan Hospital, Dalgubeol-daero, Daegu, South Korea
  2. Department of Radiation Oncology, Keimyung University School of Medicine, Dalgubeol-daero, Daegu, South Korea
J Contemp Brachytherapy 2024; 16, 3: 184–192
Online publish date: 2024/06/28
Article file
Get citation
 
 
1. Mayadev JS, Ke G, Mahantshetty U et al. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer. Int J Gynecol Cancer 2022; 32: 436-445.
2. Liu J, Tang G, Zhou Q et al. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Radiat Oncol 2022; 17: 142.
3. Cibula D, Potter R, Planchamp F et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer 2018; 28: 641-655.
4. Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health 2014; 6: 555-564.
5. Xu Z, Yang L, Ma L et al. Effect of bladder volume on radiation doses to organs at risk and tumor in cervical cancer during image-guided adaptive brachytherapy and treatment outcome analysis. Mol Clin Oncol 2021; 15: 258.
6. Buchali A, Koswig S, Dinges S et al. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiother Oncol 1999; 52: 29-34.
7. Mahantshetty U, Shetty S, Majumder D et al. Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study. J Contemp Brachytherapy 2017; 9: 112-117.
8. Sharma AD, Poddar J, Suryanarayan KU et al. Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in highdose-rate intracavitary brachytherapy in carcinoma cervix – an institutional study. J Contemp Brachytherapy 2018; 10: 26-31.
9. Taylor A, Powell ME. An assessment of interfractional uterine and cervical motion: implications for radiotherapy target volume definition in gynaecological cancer. Radiother Oncol 2008; 88: 250-257.
10. Ju SG, Huh SJ, Shin JS et al. Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer. J Radiat Res 2013; 54: 349-356.
11. Jin F, Liu Q, Luo H et al. Dynamic changes in bladder morphology over time in cervical cancer patients. Cancer Control 2021; 28: 10732748211021082.
12. Choi E, Kim JH, Kim OB et al. Dose comparison between prescription methods according to anatomical variations in intracavitary brachytherapy for cervical cancer. Radiat Oncol J 2018; 36: 227-234.
13. Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245.
14. Potter R, Haie-Meder C, Van Limbergen E et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
15. Dimopoulos JC, Petrow P, Tanderup K et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012; 103: 113-122.
16. Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. J ICRU 2013; 13: NP.
17. Siavashpour Z, Aghamiri MR, Jaberi R et al. Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy 2016; 8: 135-142.
18. Nesseler JP, Charra-Brunaud C, Salleron J et al. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guide adaptive brachytherapy for locally advanced cervical cancer. Brachytherpy 2017; 16: 976-980.
19. Ma S, Zhang T, Jiang L et al. Impact of bladder volume on treatment planning and clinical outcomes of radiotherapy for patients with cervical cancer. Cancer Manag Res 2019; 11: 7171-7181.
20. Sun LM, Huang HY, Huang EY et al. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques. Radiother Oncol 2005; 77: 77-82.
21. Yamashita H, Nakagawa K, Okuma K et al. Correlation between bladder volume and irradiated dose of small bowel in CT-based planning of intracavitary brachytherapy for cervical cancer. Jpn J Clin Oncol 2012; 42: 302-308.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.